ClinVar Miner

Submissions for variant NM_000518.5(HBB):c.316-1G>A (rs33952266)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000668023 SCV000792565 pathogenic beta Thalassemia 2017-08-22 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV001199849 SCV001370574 likely pathogenic Hemoglobinopathy 2020-05-14 criteria provided, single submitter clinical testing Variant summary: HBB c.316-1G>A (also described in the literature as IVS-II-850G>A) is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict a significant impact on normal splicing: Four predict the variant abolishes a 3 acceptor site. However, these predictions have yet to be confirmed by functional studies. The variant was absent in 251150 control chromosomes (gnomAD). c.316-1G>A has been reported in the literature in homozygous and heterozygous individuals affected with beta-thalassemia (e.g. Al Mosawi_2020). Furthermore, beta-thal trait individuals heterozygous for the variant, were reported with a history of mild anemia and microcytosis (e.g. Curuk_1995, Knott_2006). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Other variants affecting the same splice-site nucleotide (c.316-1G>C, c.316-1G>T) have been reported internally and also, in ClinVar and HGMD as pathogenic/likely pathogenic and disease-associated. Three ClinVar submitters (evaluation after 2014) cite the variant as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic.
OMIM RCV000736022 SCV000037079 pathogenic beta^0^ Thalassemia 1995-05-01 no assertion criteria provided literature only
College of Science, Al Muthanna University,Al Muthanna University RCV000668023 SCV000804462 pathogenic beta Thalassemia 2018-07-01 no assertion criteria provided research
College of Science, Al Muthanna University,Al Muthanna University RCV000736022 SCV000864065 pathogenic beta^0^ Thalassemia 2018-01-01 no assertion criteria provided research
The ITHANET community portal, The Cyprus Institute of Neurology and Genetics RCV000668023 SCV001244415 pathogenic beta Thalassemia 2019-11-25 no assertion criteria provided curation

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.